IBDEI35X ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50499,1,4,0)
;;=4^N32.89
;;^UTILITY(U,$J,358.3,50499,2)
;;=^87989
;;^UTILITY(U,$J,358.3,50500,0)
;;=N33.^^193^2494^6
;;^UTILITY(U,$J,358.3,50500,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50500,1,3,0)
;;=3^Bladder Disorders,Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,50500,1,4,0)
;;=4^N33.
;;^UTILITY(U,$J,358.3,50500,2)
;;=^5015654
;;^UTILITY(U,$J,358.3,50501,0)
;;=N34.2^^193^2494^113
;;^UTILITY(U,$J,358.3,50501,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50501,1,3,0)
;;=3^Urethritis
;;^UTILITY(U,$J,358.3,50501,1,4,0)
;;=4^N34.2
;;^UTILITY(U,$J,358.3,50501,2)
;;=^88231
;;^UTILITY(U,$J,358.3,50502,0)
;;=N34.1^^193^2494^114
;;^UTILITY(U,$J,358.3,50502,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50502,1,3,0)
;;=3^Urethritis,Nonspec
;;^UTILITY(U,$J,358.3,50502,1,4,0)
;;=4^N34.1
;;^UTILITY(U,$J,358.3,50502,2)
;;=^5015655
;;^UTILITY(U,$J,358.3,50503,0)
;;=N39.0^^193^2494^118
;;^UTILITY(U,$J,358.3,50503,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50503,1,3,0)
;;=3^Urinary Tract Infection,Site Not Spec
;;^UTILITY(U,$J,358.3,50503,1,4,0)
;;=4^N39.0
;;^UTILITY(U,$J,358.3,50503,2)
;;=^124436
;;^UTILITY(U,$J,358.3,50504,0)
;;=N31.0^^193^2494^79
;;^UTILITY(U,$J,358.3,50504,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50504,1,3,0)
;;=3^Neuropathic Bladder,Uninhibited NEC
;;^UTILITY(U,$J,358.3,50504,1,4,0)
;;=4^N31.0
;;^UTILITY(U,$J,358.3,50504,2)
;;=^5015644
;;^UTILITY(U,$J,358.3,50505,0)
;;=R31.9^^193^2494^58
;;^UTILITY(U,$J,358.3,50505,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50505,1,3,0)
;;=3^Hematuria,Unspec
;;^UTILITY(U,$J,358.3,50505,1,4,0)
;;=4^R31.9
;;^UTILITY(U,$J,358.3,50505,2)
;;=^5019328
;;^UTILITY(U,$J,358.3,50506,0)
;;=R31.0^^193^2494^55
;;^UTILITY(U,$J,358.3,50506,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50506,1,3,0)
;;=3^Hematuria,Gross
;;^UTILITY(U,$J,358.3,50506,1,4,0)
;;=4^R31.0
;;^UTILITY(U,$J,358.3,50506,2)
;;=^5019325
;;^UTILITY(U,$J,358.3,50507,0)
;;=R31.1^^193^2494^54
;;^UTILITY(U,$J,358.3,50507,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50507,1,3,0)
;;=3^Hematuria,Benign Essential Microscopic
;;^UTILITY(U,$J,358.3,50507,1,4,0)
;;=4^R31.1
;;^UTILITY(U,$J,358.3,50507,2)
;;=^5019326
;;^UTILITY(U,$J,358.3,50508,0)
;;=N40.0^^193^2494^3
;;^UTILITY(U,$J,358.3,50508,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50508,1,3,0)
;;=3^BPH w/o Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,50508,1,4,0)
;;=4^N40.0
;;^UTILITY(U,$J,358.3,50508,2)
;;=^5015689
;;^UTILITY(U,$J,358.3,50509,0)
;;=N40.1^^193^2494^2
;;^UTILITY(U,$J,358.3,50509,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50509,1,3,0)
;;=3^BPH w/ Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,50509,1,4,0)
;;=4^N40.1
;;^UTILITY(U,$J,358.3,50509,2)
;;=^5015690
;;^UTILITY(U,$J,358.3,50510,0)
;;=N41.0^^193^2494^89
;;^UTILITY(U,$J,358.3,50510,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50510,1,3,0)
;;=3^Prostatitis,Acute
;;^UTILITY(U,$J,358.3,50510,1,4,0)
;;=4^N41.0
;;^UTILITY(U,$J,358.3,50510,2)
;;=^259106
;;^UTILITY(U,$J,358.3,50511,0)
;;=N45.1^^193^2494^31
;;^UTILITY(U,$J,358.3,50511,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50511,1,3,0)
;;=3^Epididymitis
;;^UTILITY(U,$J,358.3,50511,1,4,0)
;;=4^N45.1
;;^UTILITY(U,$J,358.3,50511,2)
;;=^41396
;;^UTILITY(U,$J,358.3,50512,0)
;;=N45.2^^193^2494^81
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI35X 3753 printed Apr 09, 2024@21:53:28 Page 2
IBDEI35X ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50499,1,4,0)
+2 ;;=4^N32.89
+3 ;;^UTILITY(U,$J,358.3,50499,2)
+4 ;;=^87989
+5 ;;^UTILITY(U,$J,358.3,50500,0)
+6 ;;=N33.^^193^2494^6
+7 ;;^UTILITY(U,$J,358.3,50500,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,50500,1,3,0)
+10 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
+11 ;;^UTILITY(U,$J,358.3,50500,1,4,0)
+12 ;;=4^N33.
+13 ;;^UTILITY(U,$J,358.3,50500,2)
+14 ;;=^5015654
+15 ;;^UTILITY(U,$J,358.3,50501,0)
+16 ;;=N34.2^^193^2494^113
+17 ;;^UTILITY(U,$J,358.3,50501,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,50501,1,3,0)
+20 ;;=3^Urethritis
+21 ;;^UTILITY(U,$J,358.3,50501,1,4,0)
+22 ;;=4^N34.2
+23 ;;^UTILITY(U,$J,358.3,50501,2)
+24 ;;=^88231
+25 ;;^UTILITY(U,$J,358.3,50502,0)
+26 ;;=N34.1^^193^2494^114
+27 ;;^UTILITY(U,$J,358.3,50502,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,50502,1,3,0)
+30 ;;=3^Urethritis,Nonspec
+31 ;;^UTILITY(U,$J,358.3,50502,1,4,0)
+32 ;;=4^N34.1
+33 ;;^UTILITY(U,$J,358.3,50502,2)
+34 ;;=^5015655
+35 ;;^UTILITY(U,$J,358.3,50503,0)
+36 ;;=N39.0^^193^2494^118
+37 ;;^UTILITY(U,$J,358.3,50503,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,50503,1,3,0)
+40 ;;=3^Urinary Tract Infection,Site Not Spec
+41 ;;^UTILITY(U,$J,358.3,50503,1,4,0)
+42 ;;=4^N39.0
+43 ;;^UTILITY(U,$J,358.3,50503,2)
+44 ;;=^124436
+45 ;;^UTILITY(U,$J,358.3,50504,0)
+46 ;;=N31.0^^193^2494^79
+47 ;;^UTILITY(U,$J,358.3,50504,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,50504,1,3,0)
+50 ;;=3^Neuropathic Bladder,Uninhibited NEC
+51 ;;^UTILITY(U,$J,358.3,50504,1,4,0)
+52 ;;=4^N31.0
+53 ;;^UTILITY(U,$J,358.3,50504,2)
+54 ;;=^5015644
+55 ;;^UTILITY(U,$J,358.3,50505,0)
+56 ;;=R31.9^^193^2494^58
+57 ;;^UTILITY(U,$J,358.3,50505,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,50505,1,3,0)
+60 ;;=3^Hematuria,Unspec
+61 ;;^UTILITY(U,$J,358.3,50505,1,4,0)
+62 ;;=4^R31.9
+63 ;;^UTILITY(U,$J,358.3,50505,2)
+64 ;;=^5019328
+65 ;;^UTILITY(U,$J,358.3,50506,0)
+66 ;;=R31.0^^193^2494^55
+67 ;;^UTILITY(U,$J,358.3,50506,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,50506,1,3,0)
+70 ;;=3^Hematuria,Gross
+71 ;;^UTILITY(U,$J,358.3,50506,1,4,0)
+72 ;;=4^R31.0
+73 ;;^UTILITY(U,$J,358.3,50506,2)
+74 ;;=^5019325
+75 ;;^UTILITY(U,$J,358.3,50507,0)
+76 ;;=R31.1^^193^2494^54
+77 ;;^UTILITY(U,$J,358.3,50507,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,50507,1,3,0)
+80 ;;=3^Hematuria,Benign Essential Microscopic
+81 ;;^UTILITY(U,$J,358.3,50507,1,4,0)
+82 ;;=4^R31.1
+83 ;;^UTILITY(U,$J,358.3,50507,2)
+84 ;;=^5019326
+85 ;;^UTILITY(U,$J,358.3,50508,0)
+86 ;;=N40.0^^193^2494^3
+87 ;;^UTILITY(U,$J,358.3,50508,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,50508,1,3,0)
+90 ;;=3^BPH w/o Lower Urinary Tract Symptoms
+91 ;;^UTILITY(U,$J,358.3,50508,1,4,0)
+92 ;;=4^N40.0
+93 ;;^UTILITY(U,$J,358.3,50508,2)
+94 ;;=^5015689
+95 ;;^UTILITY(U,$J,358.3,50509,0)
+96 ;;=N40.1^^193^2494^2
+97 ;;^UTILITY(U,$J,358.3,50509,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,50509,1,3,0)
+100 ;;=3^BPH w/ Lower Urinary Tract Symptoms
+101 ;;^UTILITY(U,$J,358.3,50509,1,4,0)
+102 ;;=4^N40.1
+103 ;;^UTILITY(U,$J,358.3,50509,2)
+104 ;;=^5015690
+105 ;;^UTILITY(U,$J,358.3,50510,0)
+106 ;;=N41.0^^193^2494^89
+107 ;;^UTILITY(U,$J,358.3,50510,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,50510,1,3,0)
+110 ;;=3^Prostatitis,Acute
+111 ;;^UTILITY(U,$J,358.3,50510,1,4,0)
+112 ;;=4^N41.0
+113 ;;^UTILITY(U,$J,358.3,50510,2)
+114 ;;=^259106
+115 ;;^UTILITY(U,$J,358.3,50511,0)
+116 ;;=N45.1^^193^2494^31
+117 ;;^UTILITY(U,$J,358.3,50511,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,50511,1,3,0)
+120 ;;=3^Epididymitis
+121 ;;^UTILITY(U,$J,358.3,50511,1,4,0)
+122 ;;=4^N45.1
+123 ;;^UTILITY(U,$J,358.3,50511,2)
+124 ;;=^41396
+125 ;;^UTILITY(U,$J,358.3,50512,0)
+126 ;;=N45.2^^193^2494^81
